Ovarian Drops 5017
NDC 63083-5017, Ovarian Drops, liquid, from Professional Complementary Health Formulas.
- Product NDC
- 63083-5017
- Status
- Listed
- Labeler
- Professional Complementary Health Formulas
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63083-5017 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- VIBURNUM OPULUS BARK2 [hp_X]/59mL
- CHASTE TREE FRUIT3 [hp_X]/59mL
- ALETRIS FARINOSA ROOT4 [hp_X]/59mL
- AMARYLLIS BELLADONNA WHOLE4 [hp_X]/59mL
- DIOSCOREA VILLOSA TUBER4 [hp_X]/59mL
- APIS MELLIFERA5 [hp_X]/59mL
- BLACK COHOSH6 [hp_X]/59mL
- BOS TAURUS OVARY6 [hp_X]/59mL
- PACKERA AUREA WHOLE6 [hp_X]/59mL
- SUS SCROFA UTERUS6 [hp_X]/59mL
- GELSEMIUM SEMPERVIRENS ROOT8 [hp_X]/59mL
- MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE10 [hp_X]/59mL
Pharmacologic classes
Allergens [CS]; Bee Venoms [CS]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Standardized Insect Venom Allergenic Extract [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63083-5017-2 | 63083501702 | 59 mL in 1 BOTTLE, DROPPER (63083-5017-2) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 63083-5017 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63083-5017 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63083-5017. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.